Guy Wendy 4

What Happened
Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals, purchased 1,583 shares on April 15, 2026 at $2.97 per share, for a total cost of approximately $4,702. The reported transaction code is P (purchase), indicating an open market or private purchase. Purchases by insiders are often viewed as a more bullish signal than sales, though this is a modest-sized transaction.

Key Details

• Transaction date: 2026-04-15; Price: $2.97 per share; Shares: 1,583; Total value: ~$4,702.
• Transaction type/code: P — open market or private purchase.
• Filing date: 2026-04-17 (reported to SEC within the typical two-business-day window).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes/plan references: none reported in the provided details (no 10b5-1, tax-withholding, or gift notation shown).

Context
This is a direct insider purchase of common stock by a company executive. While insider buys can signal confidence, the relatively small dollar amount here means it should be weighed alongside other filings, company news, and financials rather than taken as a strong standalone indicator.